獸用抗生素市場分析及預測（至2035年）：類型、產品、應用、劑型、最終用戶、技術、功能與服務

預計獸用抗生素市場將從2024年的66億美元成長到2034年的124億美元，複合年成長率約為7.3%。獸用抗生素市場涵蓋用於預防、控制和治療動物細菌感染疾病的藥物。該市場成長的驅動力來自對動物性食品需求的不斷成長以及對動物健康和福利的日益重視。主要趨勢包括新型抗生素的研發和遏制抗生素抗藥性的監管措施。全球寵物主人數量和畜牧業生產的不斷成長正在推動市場成長，而專注於提高療效和安全性的技術創新則推動了市場發展，以滿足嚴格的監管標準。

獸用抗生素市場持續穩定擴張，主要驅動力是不斷成長的動物健康和食品安全需求。製藥領域是推動成長的主要動力，其中四環黴素和青黴素類抗生素因其頻譜抗菌活性而需求量最高。大環內酯類和磺胺類藥物緊隨其後，因其在治療呼吸道和腸道感染疾病的有效性而推動市場成長。飼料添加劑是第二大成長領域，這得益於其對促進牲畜生長和預防疾病的貢獻。在該領域，離子載體和益生菌正日益受到關注，反映出人們正朝著永續和預防性動物健康解決方案的方向發展。對降低抗生素抗藥性的日益重視進一步推動了市場成長，刺激了先進標靶抗生素的研發。注射用抗生素因其起效迅速和治療精準而備受關注。口服製劑仍然十分重要，尤其是在大規模畜牧業。此外，旨在創新和推出下一代獸用抗生素的研發活動也蓬勃發展。

獸用抗生素市場格局複雜多樣，主要企業佔據顯著的市場佔有率。它們透過策略定價和持續推出創新產品來維持其市場主導地位。市場成長的驅動力在於對有效動物保健解決方案的需求，尤其關注降低抗生素抗藥性。近期產品推出強調採用先進配方，以提高療效和安全性。競爭性定價策略旨在吸引更廣泛的基本客群，從而擴大市場覆蓋率和影響力。獸用抗生素產業的競爭異常激烈，主要企業透過技術創新和策略聯盟追求卓越。北美和歐洲的監管機構制定了嚴格的指導方針，影響市場動態。這些法規確保了產品的安全性和有效性，並塑造了競爭格局。此外，對有機和無抗生素產品的需求不斷成長，也影響市場，並促使製造商進行創新。隨著產業的不斷發展，能夠適應監管變化和消費者偏好的企業將迎來成長機會。

主要趨勢和促進因素：

獸用抗生素市場正經歷顯著成長，這主要得益於幾個關鍵趨勢和促進因素。人們日益增強的動物健康和福利意識是關鍵促進因素，推動了消費者對牲畜和寵物更高照護標準的需求。這促使獸用抗生素的使用量增加，用於預防和治療感染疾病，確保動物健康和生產力。獸醫學技術的進步也是一大趨勢。藥物輸送系統和製劑的創新提高了抗生素的療效和安全性，並降低了抗藥性的風險。這些進步推動了新型抗生素的研發，以滿足特定的動物健康需求，從而擴大了市場機會。另一個促進因素是動物性蛋白質需求的成長，這促使人們需要有效控制牲畜疾病。隨著全球人口的成長，肉類和乳製品的消費量也在增加，因此，高效使用抗生素對於維護動物健康和食品安全至關重要。法規結構也在不斷發展，以應對抗生素抗藥性問題，這影響著市場動態。各國政府和相關機構正在推出更嚴格的法規和指南，以促進合理使用抗生素，鼓勵開發替代解決方案，並推動市場創新。最後，寵物飼養率的上升也推動了獸用抗生素的需求。寵物飼主越來越願意在寵物的健康上投入資金，從而推動了能夠保障寵物健康的抗生素市場的發展。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 四環黴素
  • 青黴素
  • 大環內酯類
  • 磺胺類藥物
  • 奎諾酮
  • 頭孢菌素
  • Aminoglycosides
  • 林可醯胺類
• 市場規模及預測：依產品分類
  • 口服粉劑
  • 注射
  • 預混合料
  • 乳房內製劑
• 市場規模及預測：依應用領域分類
  • 家畜
  • 伴侶動物
  • 水產養殖
  • 家禽
• 市場規模及預測：依類型
  • 液體
  • 固態的
• 市場規模及預測：依最終用戶分類
  • 獸醫診所
  • 動物診所
  • 藥房和藥品商店
  • 網路藥房
• 市場規模及預測：依技術分類
  • 奈米科技
  • 封裝
  • 緩釋製劑
• 市場規模及預測：依功能分類
  • 治療
  • 預防
  • 促進生長
• 市場規模及預測：依服務分類
  • 諮詢
  • 實驗室檢測

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 需求與供給差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 法規概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 主要企業的策略

第8章 公司簡介

• Zoetis
• Elanco Animal Health
• Boehringer Ingelheim Animal Health
• Virbac
• Ceva Sante Animale
• Vetoquinol
• Phibro Animal Health
• Dechra Pharmaceuticals
• HIPRA
• Kyoritsu Seiyaku
• Norbrook Laboratories
• Ourofino Saude Animal
• Huvepharma
• Bimeda
• Zagro
• Biogenesis Bago
• Hester Biosciences
• Neogen Corporation
• Impextraco
• Eco Animal Health

第9章：關於我們

Veterinary Antibiotics Market is anticipated to expand from $6.6 billion in 2024 to $12.4 billion by 2034, growing at a CAGR of approximately 7.3%. The Veterinary Antibiotics Market encompasses pharmaceutical products designed to prevent, control, and treat bacterial infections in animals. This market is driven by the rising demand for animal-derived food products and the need for animal health and welfare. Key trends include the development of novel antibiotics and regulatory measures to curb antibiotic resistance. Increasing pet ownership and livestock production globally propel market growth, while innovations focus on efficacy and safety to meet stringent regulatory standards.

The Veterinary Antibiotics Market is experiencing robust expansion, primarily due to the rising demand for animal health and food safety. The pharmaceuticals segment leads in performance, with tetracyclines and penicillins being the most sought-after due to their broad-spectrum efficacy. Macrolides and sulfonamides closely follow, driven by their effectiveness in treating respiratory and intestinal infections. Feed additives represent the second highest performing segment, as they enhance growth and prevent disease in livestock. Within this segment, ionophores and probiotics are gaining prominence, reflecting a shift towards sustainable and preventive animal health solutions. The increasing focus on reducing antibiotic resistance further propels the market, encouraging the development of advanced, targeted antibiotics. Injectable antibiotics are gaining traction due to their rapid action and precision in treatment. Oral formulations remain significant, especially in large-scale livestock operations. The market is also witnessing a surge in research and development activities, aiming to innovate and introduce next-generation antibiotics for veterinary applications.

The veterinary antibiotics market is characterized by a diverse landscape, with leading companies holding significant market share. This dominance is maintained through strategic pricing and the continuous launch of innovative products. The market is driven by the need for effective animal health solutions, with a focus on reducing antibiotic resistance. Recent product launches have emphasized advanced formulations that enhance efficacy and safety. The competitive pricing strategies are designed to capture a broader customer base, thereby expanding market reach and influence. Competition in the veterinary antibiotics sector is fierce, with key players striving for excellence through technological innovation and strategic partnerships. Regulatory bodies in North America and Europe impose stringent guidelines, impacting the market dynamics. These regulations ensure product safety and efficacy, shaping the competitive landscape. The market is further influenced by the increasing demand for organic and antibiotic-free products, prompting manufacturers to innovate. As the industry evolves, companies that adapt to regulatory changes and consumer preferences are poised for growth.

Geographical Overview:

The veterinary antibiotics market is witnessing robust growth across diverse regions, each displaying unique dynamics. North America leads the market, driven by advanced veterinary healthcare infrastructure and heightened awareness regarding animal health. The region's stringent regulations on antibiotic use in livestock also contribute to its market dynamics, encouraging the development of alternative solutions. Europe follows closely, with its strong emphasis on sustainable farming practices and animal welfare. The European Union's regulations on antibiotic use in animals are fostering innovation in veterinary pharmaceuticals. This has led to an increase in research and development activities, creating new growth pockets in the region. In Asia Pacific, the market is expanding rapidly, fueled by a growing livestock population and rising demand for animal-derived food products. Emerging economies like China and India present significant opportunities due to their large-scale livestock operations and increasing focus on animal health. Latin America and the Middle East & Africa are also emerging markets, showing potential for growth. Increasing investments in veterinary healthcare infrastructure and rising awareness about animal health are driving market expansion in these regions.

The Veterinary Antibiotics Market is increasingly shaped by global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are strategically investing in domestic production capabilities to mitigate reliance on imports and counteract tariff impacts. China's focus on indigenous pharmaceutical development is intensifying amid trade restrictions, aiming to bolster self-sufficiency. Taiwan, with its advanced biotech sector, is navigating geopolitical complexities to maintain its supply chain resilience. Globally, the parent market is experiencing steady growth driven by rising demand for animal health solutions. By 2035, the market is poised for significant expansion, contingent on strategic regional collaborations and supply chain innovations. Concurrently, Middle East conflicts continue to exert pressure on global energy prices, indirectly influencing production costs and market stability.

Key Trends and Drivers:

The veterinary antibiotics market is experiencing significant growth, driven by several key trends and drivers. Increasing awareness of animal health and welfare is a primary factor, as consumers demand higher standards of care for livestock and pets. This is leading to a rise in the adoption of veterinary antibiotics to prevent and treat infections, ensuring the health and productivity of animals. Technological advancements in veterinary medicine are also a major trend. Innovations in drug delivery systems and formulations are enhancing the efficacy and safety of antibiotics, reducing the risk of resistance. These advancements are fostering the development of novel antibiotics that cater to specific animal health needs, thus expanding market opportunities. Another driver is the growing demand for animal protein, which is propelling the need for effective disease management in livestock. As global populations increase, so does the consumption of meat and dairy products, necessitating efficient antibiotic use to maintain animal health and food safety. Regulatory frameworks are evolving to address antibiotic resistance concerns, influencing market dynamics. Governments and organizations are implementing stricter regulations and guidelines to promote responsible antibiotic use, encouraging the development of alternative solutions and fostering market innovation. Finally, the rise of companion animal ownership is boosting the demand for veterinary antibiotics. Pet owners are increasingly willing to invest in the health of their animals, driving the market for antibiotics that ensure the well-being of pets.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Application
• 2.4 Key Market Highlights by Form
• 2.5 Key Market Highlights by End User
• 2.6 Key Market Highlights by Technology
• 2.7 Key Market Highlights by Functionality
• 2.8 Key Market Highlights by Services

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Tetracyclines
  • 4.1.2 Penicillins
  • 4.1.3 Macrolides
  • 4.1.4 Sulfonamides
  • 4.1.5 Quinolones
  • 4.1.6 Cephalosporins
  • 4.1.7 Aminoglycosides
  • 4.1.8 Lincosamides
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Oral Powder
  • 4.2.2 Injection
  • 4.2.3 Premix
  • 4.2.4 Intramammary Preparations
• 4.3 Market Size & Forecast by Application (2020-2035)
  • 4.3.1 Livestock
  • 4.3.2 Companion Animals
  • 4.3.3 Aquaculture
  • 4.3.4 Poultry
• 4.4 Market Size & Forecast by Form (2020-2035)
  • 4.4.1 Liquid
  • 4.4.2 Solid
• 4.5 Market Size & Forecast by End User (2020-2035)
  • 4.5.1 Veterinary Hospitals
  • 4.5.2 Veterinary Clinics
  • 4.5.3 Pharmacies and Drug Stores
  • 4.5.4 Online Pharmacies
• 4.6 Market Size & Forecast by Technology (2020-2035)
  • 4.6.1 Nanotechnology
  • 4.6.2 Encapsulation
  • 4.6.3 Controlled Release
• 4.7 Market Size & Forecast by Functionality (2020-2035)
  • 4.7.1 Therapeutic
  • 4.7.2 Prophylactic
  • 4.7.3 Growth Promotion
• 4.8 Market Size & Forecast by Services (2020-2035)
  • 4.8.1 Consultation
  • 4.8.2 Laboratory Testing

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Application
    • 5.2.1.4 Form
    • 5.2.1.5 End User
    • 5.2.1.6 Technology
    • 5.2.1.7 Functionality
    • 5.2.1.8 Services
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Application
    • 5.2.2.4 Form
    • 5.2.2.5 End User
    • 5.2.2.6 Technology
    • 5.2.2.7 Functionality
    • 5.2.2.8 Services
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Application
    • 5.2.3.4 Form
    • 5.2.3.5 End User
    • 5.2.3.6 Technology
    • 5.2.3.7 Functionality
    • 5.2.3.8 Services
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Application
    • 5.3.1.4 Form
    • 5.3.1.5 End User
    • 5.3.1.6 Technology
    • 5.3.1.7 Functionality
    • 5.3.1.8 Services
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Application
    • 5.3.2.4 Form
    • 5.3.2.5 End User
    • 5.3.2.6 Technology
    • 5.3.2.7 Functionality
    • 5.3.2.8 Services
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Application
    • 5.3.3.4 Form
    • 5.3.3.5 End User
    • 5.3.3.6 Technology
    • 5.3.3.7 Functionality
    • 5.3.3.8 Services
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Application
    • 5.4.1.4 Form
    • 5.4.1.5 End User
    • 5.4.1.6 Technology
    • 5.4.1.7 Functionality
    • 5.4.1.8 Services
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Application
    • 5.4.2.4 Form
    • 5.4.2.5 End User
    • 5.4.2.6 Technology
    • 5.4.2.7 Functionality
    • 5.4.2.8 Services
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Application
    • 5.4.3.4 Form
    • 5.4.3.5 End User
    • 5.4.3.6 Technology
    • 5.4.3.7 Functionality
    • 5.4.3.8 Services
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Application
    • 5.4.4.4 Form
    • 5.4.4.5 End User
    • 5.4.4.6 Technology
    • 5.4.4.7 Functionality
    • 5.4.4.8 Services
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Application
    • 5.4.5.4 Form
    • 5.4.5.5 End User
    • 5.4.5.6 Technology
    • 5.4.5.7 Functionality
    • 5.4.5.8 Services
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Application
    • 5.4.6.4 Form
    • 5.4.6.5 End User
    • 5.4.6.6 Technology
    • 5.4.6.7 Functionality
    • 5.4.6.8 Services
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Application
    • 5.4.7.4 Form
    • 5.4.7.5 End User
    • 5.4.7.6 Technology
    • 5.4.7.7 Functionality
    • 5.4.7.8 Services
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Application
    • 5.5.1.4 Form
    • 5.5.1.5 End User
    • 5.5.1.6 Technology
    • 5.5.1.7 Functionality
    • 5.5.1.8 Services
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Application
    • 5.5.2.4 Form
    • 5.5.2.5 End User
    • 5.5.2.6 Technology
    • 5.5.2.7 Functionality
    • 5.5.2.8 Services
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Application
    • 5.5.3.4 Form
    • 5.5.3.5 End User
    • 5.5.3.6 Technology
    • 5.5.3.7 Functionality
    • 5.5.3.8 Services
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Application
    • 5.5.4.4 Form
    • 5.5.4.5 End User
    • 5.5.4.6 Technology
    • 5.5.4.7 Functionality
    • 5.5.4.8 Services
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Application
    • 5.5.5.4 Form
    • 5.5.5.5 End User
    • 5.5.5.6 Technology
    • 5.5.5.7 Functionality
    • 5.5.5.8 Services
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Application
    • 5.5.6.4 Form
    • 5.5.6.5 End User
    • 5.5.6.6 Technology
    • 5.5.6.7 Functionality
    • 5.5.6.8 Services
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Application
    • 5.6.1.4 Form
    • 5.6.1.5 End User
    • 5.6.1.6 Technology
    • 5.6.1.7 Functionality
    • 5.6.1.8 Services
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Application
    • 5.6.2.4 Form
    • 5.6.2.5 End User
    • 5.6.2.6 Technology
    • 5.6.2.7 Functionality
    • 5.6.2.8 Services
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Application
    • 5.6.3.4 Form
    • 5.6.3.5 End User
    • 5.6.3.6 Technology
    • 5.6.3.7 Functionality
    • 5.6.3.8 Services
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Application
    • 5.6.4.4 Form
    • 5.6.4.5 End User
    • 5.6.4.6 Technology
    • 5.6.4.7 Functionality
    • 5.6.4.8 Services
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Application
    • 5.6.5.4 Form
    • 5.6.5.5 End User
    • 5.6.5.6 Technology
    • 5.6.5.7 Functionality
    • 5.6.5.8 Services

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Zoetis
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Elanco Animal Health
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Boehringer Ingelheim Animal Health
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Virbac
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Ceva Sante Animale
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Vetoquinol
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Phibro Animal Health
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Dechra Pharmaceuticals
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 HIPRA
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Kyoritsu Seiyaku
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Norbrook Laboratories
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Ourofino Saude Animal
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Huvepharma
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Bimeda
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Zagro
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Biogenesis Bago
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Hester Biosciences
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Neogen Corporation
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Impextraco
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Eco Animal Health
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us